Treatment Advances in Myeloma: Expert Perspectives on Translating Clinical Data to Practice

Treatment Advances in Multiple Myeloma: Expert Perspectives on Translating Clinical Data to Practice

Join us for a provocative program that includes interactive case discussions and a review of the data from a panel of renowned myeloma experts who will provide varied perspectives on new data, guideline changes, and expert recommendations for management of patients with multiple myeloma.

Interact with these international experts as they debate clinical questions and discuss how these challenges can affect therapeutic decisions faced by clinicians treating myeloma.

Agenda

12:30 PM - 12:35 PM Welcome and Introduction
Brian G.M. Durie, MD, Program Director and Moderator

12:35 PM - 1:05 PM Case Discussion 1
Diagnosing MM: When Should Treatment Be Initiated?
S. Vincent Rajkumar, MD

Faculty will discuss the controversies regarding the updated diagnostic criteria, patients who are not within diagnostic criteria but who are at risk, and when to treat patients with MM.

Faculty Panel Discussion and Audience Questions
Summary and Review of Key Take-Home Points

1:05 PM - 1:50 PM Case Discussion 2
Should We Be Using Risk-Adapted Therapy in Clinical Practice?
Shaji Kumar, MD, and Philippe Moreau, MD

Faculty will discuss the controversies regarding selecting treatment for newly diagnosed MM, including how to individualize therapy based on cytogenetic risk factors, patient age, and the presence of specific comorbidities.

Faculty Panel Discussion and Audience Questions
Summary and Review of Key Take-Home Points

1:50 PM - 2:20 PM Case Discussion 3
How Should We Use Maintenance for Patients in Clinical Practice?
Bruno Paiva, PhD, and Jesús F. San-Miguel, MD, PhD

Faculty will discuss the use of maintenance therapy for patients with MM as well as controversies regarding minimal residual disease and its use in guiding treatment decisions.

Faculty Panel Discussion and Audience Questions
Summary and Review of Key Take-Home Points

2:20 PM - 3:05 PM Case Discussion 4
How Do You Choose the Best Treatment Regimens for Relapsed/Refractory Disease?
Philippe Moreau, MD

Faculty will debate the issues regarding the optimal current salvage treatments and choosing between traditional agents or new options for patients with relapsed/refractory MM.

Faculty Panel Discussion and Audience Questions
Summary and Review of Key Take-Home Points

3:05 PM - 3:25 PM Where Are We Now and Where Are We Going With the Care of Patients With MM?

Brian G.M. Durie, MD, will lead a panel discussion on the current state of MM treatment.

3:25 PM - 3:30 PM Concluding Remarks
Brian G.M. Durie, MD, Program Director and Moderator

Please subscribe to our channel!

Find us online:

Category
Nonprofits & Activism
License
Standard YouTube License